1. Home
  2. NYT vs PEN Comparison

NYT vs PEN Comparison

Compare NYT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New York Times Company (The)

NYT

New York Times Company (The)

HOLD

Current Price

$68.61

Market Cap

12.2B

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

N/A

Current Price

$324.37

Market Cap

12.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NYT
PEN
Founded
1851
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2B
12.6B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
NYT
PEN
Price
$68.61
$324.37
Analyst Decision
Buy
Hold
Analyst Count
7
16
Target Price
$72.14
$360.14
AVG Volume (30 Days)
2.3M
250.2K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
1.16%
N/A
EPS Growth
18.08
1155.56
EPS
1.11
1.70
Revenue
$1,783,639,000.00
$1,403,665,000.00
Revenue This Year
$10.58
$14.34
Revenue Next Year
$6.98
$13.71
P/E Ratio
$60.80
$190.44
Revenue Growth
N/A
17.50
52 Week Low
$54.10
$221.26
52 Week High
$87.10
$362.41

Technical Indicators

Market Signals
Indicator
NYT
PEN
Relative Strength Index (RSI) 46.50 52.04
Support Level $63.05 $315.31
Resistance Level $71.78 $329.14
Average True Range (ATR) 1.43 1.88
MACD 0.34 -0.38
Stochastic Oscillator 86.08 10.52

Price Performance

Historical Comparison
NYT
PEN

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company derives revenue from subscriptions, advertising, and other sources, where the majority of its revenue is generated through subscriptions, which consist of income from standalone and multiproduct bundle subscriptions to its digital products and subscriptions to and single-copy and bulk sales of print products.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: